[HTML][HTML] Tumor regression and allograft rejection after administration of anti–PD-1

EJ Lipson, SM Bagnasco, J Moore Jr… - … England Journal of …, 2016 - Mass Medical Soc
EJ Lipson, SM Bagnasco, J Moore Jr, S Jang, MJ Patel, AA Zachary, DM Pardoll, JM Taube
New England Journal of Medicine, 2016Mass Medical Soc
Tumor Regression and Allograft Rejection after Administration of Anti–PD-1 | NEJM Skip to
main content NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare
to become a physician, build your knowledge, lead a health care organization, and advance
your career with NEJM Group information and services. NEJM Evidence NEW! A digital journal
for innovative original research and fresh, bold ideas in clinical trial design and clinical
decision-making. NEJM Catalyst NEW! Peer-reviewed journal featuring in-depth articles to …
Cancers, especially skin cancers, may develop in patients undergoing solid-organ transplantation who receive long-term immunosuppression. The use of anti–PD-1 in one such patient produced an antitumor response but led to rejection of the transplanted kidney.
The New England Journal Of Medicine